OBJECTIVE: The purpose of this study was to determine the efficacy and safety of omega-3 fatty acids for children with autistic spectrum disorder (ASD). METHODS: This was an open-label pilot study. Ten children aged 4-7 years old with ASD according to the Diagnostic and Statistical Manual of Mental Disorders, 4(th) edition (DSM-IV), were given 1 gram daily of omega-3 fatty acids for 12 weeks. The main outcome measure used was the Autism Treatment Evaluation Checklist (ATEC). These data were collected between July, 2006, and June, 2007. RESULTS: Of the 9 subjects who completed the study, 8 showed improvement of about 33% on the Autism Treatment Evaluation Checklist (ATEC). None worsened and no side effects were reported. CONCLUSIONS: Omega-3 fatty acids appear to be safe and might be helpful for children suffering from ASD. Further study is needed with a larger number of children in a double-blind design and with various doses of omega-3 fatty acids.
OBJECTIVE: The purpose of this study was to determine the efficacy and safety of omega-3 fatty acids for children with autistic spectrum disorder (ASD). METHODS: This was an open-label pilot study. Ten children aged 4-7 years old with ASD according to the Diagnostic and Statistical Manual of Mental Disorders, 4(th) edition (DSM-IV), were given 1 gram daily of omega-3 fatty acids for 12 weeks. The main outcome measure used was the Autism Treatment Evaluation Checklist (ATEC). These data were collected between July, 2006, and June, 2007. RESULTS: Of the 9 subjects who completed the study, 8 showed improvement of about 33% on the Autism Treatment Evaluation Checklist (ATEC). None worsened and no side effects were reported. CONCLUSIONS:Omega-3 fatty acids appear to be safe and might be helpful for children suffering from ASD. Further study is needed with a larger number of children in a double-blind design and with various doses of omega-3 fatty acids.
Authors: Antonio Y Hardan; Lawrence K Fung; Robin A Libove; Tetyana V Obukhanych; Surekha Nair; Leonore A Herzenberg; Thomas W Frazier; Rabindra Tirouvanziam Journal: Biol Psychiatry Date: 2012-02-18 Impact factor: 13.382
Authors: Sarah A Keim; Barbara Gracious; Kelly M Boone; Mark A Klebanoff; Lynette K Rogers; Joseph Rausch; Daniel L Coury; Kelly W Sheppard; Jesse Husk; Dale A Rhoda Journal: J Nutr Date: 2018-02-01 Impact factor: 4.798
Authors: Sarah L Logan; Joyce S Nicholas; Laura A Carpenter; Lydia B King; Elizabeth Garrett-Mayer; Jane M Charles Journal: Ann Epidemiol Date: 2012-01 Impact factor: 3.797
Authors: Y P Ooi; S-J Weng; L Y Jang; L Low; J Seah; S Teo; R P Ang; C G Lim; A Liew; D S Fung; M Sung Journal: Eur J Clin Nutr Date: 2015-03-25 Impact factor: 4.016
Authors: Kelly M Boone; Mark A Klebanoff; Lynette K Rogers; Joseph Rausch; Daniel L Coury; Sarah A Keim Journal: Early Hum Dev Date: 2022-05-19 Impact factor: 2.699
Authors: Richard E Frye; Daniel Rossignol; Manuel F Casanova; Gregory L Brown; Victoria Martin; Stephen Edelson; Robert Coben; Jeffrey Lewine; John C Slattery; Chrystal Lau; Paul Hardy; S Hossein Fatemi; Timothy D Folsom; Derrick Macfabe; James B Adams Journal: Front Public Health Date: 2013-09-13
Authors: Janet K Kern; Carolyn R Garver; Jyutika A Mehta; Patricia A Hannan; Liz E Bakken; Aileen M Vidaud; Judie Abraham; Yahya Daoud Journal: Yale J Biol Med Date: 2013-06-13